Search

everythinglearnresearchcommunity

for

Search:↓

Autologous platelet concentrates show promise in esthetic treatments but need more standardized research.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Early intervention and protective measures are crucial for managing CIPA due to the lack of pain and standard treatment.

PRP shows promise for eye disease in animals but needs more research before being standard care.

Most cats with dermatophytosis had fungal infections, mainly caused by M. canis.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Stem cell therapy shows promise for better burn healing but needs more research and standardization.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

The EMG-to-force model accurately predicts hip muscle forces during walking.

The document concludes that a Quality Management System is crucial for maintaining product quality through innovation and proper technology transfer in the pharmaceutical industry.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

Method detects finasteride in plasma and semen with high sensitivity and accuracy.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

Use good lighting, consistent positioning, and proper camera settings for effective hair disorder photos.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

Povidone iodine reduced skin bacteria more than chlorhexidine gluconate, but neither met FDA reduction standards.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Lichen planopilaris in men often involves scalp redness and itching, with some also having hair loss, mucosal lichen planus, or thyroid disease, and treatment improved symptoms in nearly half of the cases.

PCOS affects 11% of women, highlighting the need for standardized diagnosis.

PRP treatment can safely improve short-term vision in acute NAION patients.

Chronic kidney disease can cause skin issues that need early recognition and combined treatment for better outcomes.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

Injectable PRF therapy may help with hair growth and skin rejuvenation, but more research is needed.

Topical finasteride might help with male hair loss with fewer side effects than pills, but more research is needed.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.